These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3422208)

  • 21. Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin.
    Macchia V; Mariano A; Cavalcanti M; Coppa A; Cecere C; Fraioli G; Elia S; Ferrante G
    Int J Biol Markers; 1987; 2(3):151-6. PubMed ID: 2836526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictive value of a combination of tumor markers in monitoring patients with ovarian cancer.
    Lahousen M; Stettner H; Pickel H; Urdl W; Pürstner P
    Cancer; 1987 Nov; 60(9):2228-32. PubMed ID: 3481557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid.
    Lellé RJ; Henkel E; Leinemann D; Goeschen K
    Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Field trial of the early detection in patients with ovarian cancer].
    Kobayashi H; Sumimoto K; Terao T; Kawashima Y; Kouda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1743-9. PubMed ID: 2480393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ovarian cancer--a comparison between CT diagnosis and serum tumor markers].
    Wakabayashi Y; Yachida M; Akata S; Kawana K; Kotake F; Kakizaki D; Abe K; Negishi N; Akiya K
    Gan No Rinsho; 1988 Jan; 34(1):52-6. PubMed ID: 3422324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancer.
    Fioretti P; Gadducci A; Ferdeghini M; Bartolini T; Scatena P; Facchini V; Bianchi R
    Eur J Gynaecol Oncol; 1986; 7(3):200-5. PubMed ID: 3465535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Field trial for the early detection of patients with ovarian cancer].
    Kobayashi H; Terao T
    Rinsho Byori; 1992 Feb; 40(2):139-45. PubMed ID: 1374818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
    Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y
    Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
    Haglund C
    Br J Cancer; 1986 Dec; 54(6):897-901. PubMed ID: 3467786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of serum markers in the diagnosis and management of laryngeal cancer.
    Mevio E; Benazzo M; Galioto P; Spriano P; Pizzala R
    Clin Otolaryngol Allied Sci; 1991 Feb; 16(1):90-2. PubMed ID: 2032368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Auxiliary value of TPA in diagnosing neoplastic diseases].
    Mizushima Y; Nakamura F; Yokoyama A; Morikage T; Kawasaki S; Hoshino K; Maruyama M; Yamashita N; Yano S
    Gan No Rinsho; 1986 Jun; 32(7):779-82. PubMed ID: 3735675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
    Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T; Maruo T; Iwasaki M; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
    Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels].
    Iwanari O; Miyako J; Date Y; Moriyama M; Yoshino N; Kijima S; Nakayama S; Ryuhkoh K; Moriyama M; Hata T
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1256-60. PubMed ID: 2571650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application value of the detection of the level of tissue polypeptide antigen, ovarian cancer antigen X1, cathepsin L and CA125 on the diagnosis of epithelial ovarian cancer.
    Lv XL; Zhu Y; Liu JW; Ai H
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5113-5116. PubMed ID: 28051260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.